Cargando…

Clinical characteristics and predictors of mortality in patients with normal wall thickness cardiac amyloidosis

Detalles Bibliográficos
Autores principales:	Bhatti, Sabha, Watts, Evan, Vallurupalli, Srikanth, Pandey, Tarun, Hakeem, Abdul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032594/ http://dx.doi.org/10.1186/1532-429X-18-S1-P131

Ejemplares similares

Determination of strain pattern in patients with cardiac amyloidosis secondary to Multiple myeloma: a feature tracking study
por: Bhatti, Sabha, et al.
Publicado: (2016)

Prognostic utility of late gadolinium enhancement on cardiac magnetic resonance in cardiac amyloidosis: a meta-analysis
por: Raina, Sameer, et al.
Publicado: (2016)

Extrapolating echocardiographic determinants of elevated Left Atrial Pressure (LAP) to Cardiac Magnetic Resonance Imaging (CMR) to determine the best CMR correlate of elevated LAP
por: Rao Edupuganti, Mohan Mallikarjuna, et al.
Publicado: (2016)

Late gadolinium enhancement (LGE) on Cardiac MR is a powerful predictor of death and “hard” events in patients with hypertrophic cardiomyopathy (HCM)
por: Bhatti, Sabha, et al.
Publicado: (2012)

Correlation between Echocardiographic Pulmonary Artery Pressure Estimates and Right Heart Catheterization Measurement in Liver Transplant Candidates
por: Habash, Fuad, et al.
Publicado: (2018)

Thickness of the midventricular left ventricular wall is predictive of survival in different forms of cardiac amyloidosis
por: aus dem Siepen, Fabian, et al.
Publicado: (2013)

Cardiac Amyloidosis with Normal Wall Thickness: Prevalence, Clinical Characteristics and Outcome in a Retrospective Analysis
por: Nagy, Daniella, et al.
Publicado: (2022)

LGE-PSIR is an independent predictor of mortality in cardiac amyloidosis: a 250 patient prospective study
por: Fontana, Marianna, et al.
Publicado: (2015)

Does presence of R wave forces on surface electrocardiogram predict myocardial viability in patients with coronary disease and left ventricular dysfunction? Correlation with cardiac MRI
por: Singh, Gurjit, et al.
Publicado: (2013)

Multimodality Imaging for Diagnosing Transthyretin Cardiac Amyloidosis
por: Palot Manzil, Fathima Fijula, et al.
Publicado: (2023)

Detection of LV function abnormality using temporal patterns of normalized wall thickness
por: Wael, Mai, et al.
Publicado: (2015)

Predictors of Mortality in Light Chain Cardiac Amyloidosis with Heart Failure
por: Tahir, Usman A., et al.
Publicado: (2019)

MRI strain analysis as a novel modality for the assessment of myocardial function following stem cell therapy-results from Amorcyte trial
por: Bhatti, Sabha, et al.
Publicado: (2011)

The right ventricular end-systolic volume index predicts mortality in patients with cardiac amyloidosis
por: Wan, Ke, et al.
Publicado: (2016)

Evaluation of myocardial strain in patients with myocardial amyloidosis using feature-tracking technique
por: Pandey, Tarun, et al.
Publicado: (2016)

Native T1 mapping in ATTR cardiac amyloidosis - comparison with AL cardiac amyloidosis - a 200 patient study
por: Fontana, Marianna, et al.
Publicado: (2014)

Cardiac Angiosarcoma-Associated Membranoproliferative Glomerulonephropathy
por: Shahani, Lokesh, et al.
Publicado: (2011)

Analysis of disease progression in patients with transthyretin cardiac amyloidosis
por: Gilmore, Julian D, et al.
Publicado: (2015)

Comparison of right ventricular involvement in AL and transthyretin-type cardiac amyloidosis by cardiovascular magnetic resonance
por: Appelbaum, Evan, et al.
Publicado: (2009)

Effectiveness of Percutaneous Coronary Intervention With Drug‐Eluting Stents Compared With Bypass Surgery in Diabetics With Multivessel Coronary Disease: Comprehensive Systematic Review and Meta‐analysis of Randomized Clinical Data
por: Hakeem, Abdul, et al.
Publicado: (2013)

Reference values for the left ventricular wall thickness in cardiac MRI in a modified AHA 17-segment model
por: Andre, Florian, et al.
Publicado: (2012)

Cardiac involvement in cardiac AL amyloidosis as measured by equilibrium contrast cardiovascular magnetic resonance
por: Banypersad, Sanjay M, et al.
Publicado: (2012)

Diuretic Dose and NYHA Functional Class Are Independent Predictors of Mortality in Patients With Transthyretin Cardiac Amyloidosis
por: Cheng, Richard K., et al.
Publicado: (2020)

Hypertensive heart disease versus hypertrophic cardiomyopathy: multi-parametric CMR predictors beyond end-diastolic wall thickness ≥15mm
por: Rodrigues, Jonathan C, et al.
Publicado: (2016)

Pre-contrast ShMOLLI T1 mapping in cardiac AL amyloidosis
por: Karamitsos, Theodoros, et al.
Publicado: (2012)

Atrial delayed enhancement is associated with the severity of diastolic dysfunction in cardiac amyloidosis
por: Pozo, Eduardo, et al.
Publicado: (2013)

Feature tracking cardiac magnetic resonance in systemic light chain amyloidosis
por: Kammerer, Rebekka, et al.
Publicado: (2013)

Comparison of late gadolinium enhancement patterns in different forms of cardiac amyloidosis
por: Kammerer, Rebekka, et al.
Publicado: (2013)

Cardiac magnetic resonance strain imaging in systemic light chain amyloidosis
por: Andre, Florian, et al.
Publicado: (2014)

Posterior longitudinal strain by speckle tracking echocardiography, marker of cardiac amyloidosis?
por: Ternacle, Julien, et al.
Publicado: (2015)

Role of cardiovascular magnetic resonance in suspected cardiac amyloidosis: late gadolinium enhancement pattern as mortality predictor
por: Baroni, M., et al.
Publicado: (2017)

Prospective Evaluation of the Strategy of Functionally Optimized Coronary Intervention
por: Uretsky, Barry F., et al.
Publicado: (2020)

Distinguishing Cardiac Amyloidosis and Hypertrophic Cardiomyopathy by Thickness and Myocardial Deformation of the Right Ventricle
por: Liu, Hui, et al.
Publicado: (2022)

Novel quantification of extracellular expansion by cardiac magnetic resonance is a robust marker in diagnosis of cardiac amyloidosis
por: Mongeon, Francois-Pierre, et al.
Publicado: (2011)

Delayed hyper-enhancement cardiac magnetic resonance provides incremental prognostic value in patients with cardiac amyloidosis
por: Austin, Bethany A, et al.
Publicado: (2009)

Detection of Cardiac Function Abnormality from MRI Images Using Normalized Wall Thickness Temporal Patterns
por: Wael, Mai, et al.
Publicado: (2016)

Patterns of late gadolinium enhancement in 94 patients with AL or transthyretin cardiac amyloidosis
por: Dungu, Jason, et al.
Publicado: (2012)

Prevalence, risk factors and correlation with cardiac involvement of carpal tunnel syndrome in amyloidosis
por: Milandri, Agnese, et al.
Publicado: (2015)

Comparison and identification of early clinical, biological and echocardiographic prognostic markers in cardiac amyloidosis
por: Damy, Thibaud, et al.
Publicado: (2015)

Extensive cardiac FDG uptake in a patient with AL amyloidosis
por: Hatipoglu, Suzan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9gvdcj3hu2sfbaec8n3pd1ver4